Europe and US restrict ketoconazole use

26 July 2013 - Deborah Wilkes

Archived

Regulatory agencies in Europe and the US have taken action against oral medicines containing ketoconazole, including Johnson & Johnson's Nizoral, because they are associated with a risk of liver injury. Topical formulations are not affected by the measures.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: